Care of diabetes in children and adolescents: controversies, changes, and consensus (Q38502143)

3 September 2017

1 reference

title

Care of diabetes in children and adolescents: controversies, changes, and consensus (English)

1 reference

3 September 2017

1 reference

1

Fergus J Cameron

1 reference

3 September 2017

Diane K Wherrett

2

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 May 2015

1 reference

3 September 2017

1 reference

3 September 2017

volume

385

1 reference

3 September 2017

issue

9982

1 reference

3 September 2017

page(s)

2096-2106

1 reference

Diabetes in the young - a global view and worldwide estimates of numbers of children with type 1 diabetes.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Incidence of Type 1 Diabetes in Finland

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Prevalence of diabetes in U.S. youth in 2009: the SEARCH for diabetes in youth study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children: a prospective national surveillance study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Incidence of diabetes in youth in the United States

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

ISPAD Clinical Practice Consensus Guidelines 2014. Type 2 diabetes in the child and adolescent

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

1 reference

7 January 2021

Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Enteroviruses as causative agents in type 1 diabetes: loose ends or lost cause?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Type 2 Diabetes in Youth: Epidemiology and Pathophysiology

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

A clinical trial to maintain glycemic control in youth with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Diabetic ketoacidosis among obese African-American adolescents with NIDDM.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Diabetes mellitus in neonates and infants: genetic heterogeneity, clinical approach to diagnosis, and therapeutic options

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Management of newly diagnosed type 2 Diabetes Mellitus (T2DM) in children and adolescents

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Maturity onset diabetes of the young: identification and diagnosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: a systematic review.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Identifying targets to reduce the incidence of diabetic ketoacidosis at diagnosis of type 1 diabetes in the UK.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Campaign for diabetic ketoacidosis prevention still effective 8 years later

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Is diabetic ketoacidosis at disease onset a result of missed diagnosis?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Diabetic ketoacidosis at diagnosis in Austrian children: a population-based analysis, 1989-2011.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

A diabetes awareness campaign prevents diabetic ketoacidosis in children at their initial presentation with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT): urinary screening and baseline biochemical and cardiovascular assessments

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Changes in insulin therapy regimens over 10 yr in children and adolescents with type 1 diabetes attending diabetes camps.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Lessons from the Hvidoere International Study Group on childhood diabetes: be dogmatic about outcome and flexible in approach

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Hemoglobin A1c Levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Reducing rates of severe hypoglycemia in a population-based cohort of children and adolescents with type 1 diabetes over the decade 2000-2009

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Improved metabolic control in children and adolescents with type 1 diabetes: a trend analysis using prospective multicenter data from Germany and Austria.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: the "gift" that keeps on giving!

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

How to Apply the Experience from the Diabetes Control and Complications Trial to Children and Adolescents?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study group

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Commentary: Politics of affordable insulin

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Improving glycaemic control in children and adolescents: which aspects of therapy really matter?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Care delivery and outcomes among Belgian children and adolescents with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Improved metabolic control in pediatric patients with type 1 diabetes: a nationwide prospective 12-year time trends analysis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Continuous glucose monitoring and intensive treatment of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Use of continuous glucose monitoring in children and adolescents (*).

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Efficacy of carbohydrate counting in type 1 diabetes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Carbohydrate counting with an automated bolus calculator helps to improve glycaemic control in children with type 1 diabetes using multiple daily injection therapy: an 18-month observational study.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Recruitment to a clinical trial improves glycemic control in patients with diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Self-management competence as a predictor of outcomes of intensive therapy or usual care in youth with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Family conflict, adherence, and glycaemic control in youth with short duration Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

ISPAD Clinical Practice Consensus Guidelines 2014. Psychological care of children and adolescents with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Earlier onset of complications in youth with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Joining Forces: A Call for Greater Collaboration to Study New Medicines in Children and Adolescents With Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

The 16-year incidence, progression and regression of diabetic retinopathy in a young population-based Danish cohort with type 1 diabetes mellitus: The Danish cohort of pediatric diabetes 1987 (DCPD1987).

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

The predictive value of microalbuminuria in IDDM. A five-year follow-up study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin Diabetes Registry Study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Decline in the cumulative incidence of severe diabetic retinopathy in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Glycemic Control and Excess Mortality in Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Immune therapy in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Immune modulation in humans: implications for type 1 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Reversal of early abnormalities in glucose metabolism in obese youth: results of an intensive lifestyle randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Continuous glucose monitoring and closed-loop systems

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Outpatient glycemic control with a bionic pancreas in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Nocturnal glucose control with an artificial pancreas at a diabetes camp

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

Nice insulins, pity about the evidence

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(15)60971-0

7 January 2021

10.1016/S0140-6736(15)60971-0

Identifiers

DOI

1 reference

release_f2txi7ib5jg6noubapssur4ygi

3 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/f2txi7ib5jg6noubapssur4ygi

24 November 2022

mapped directly with Wikidata item

1 reference